EP2922877
IMPROVED PEPTIDE PHARMACEUTICALS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
20.11.2013EP published:
5.9.2018EP application number:
13857269.8
EPO information:
European Patent Register
Max expiry date:
19.11.2033
Title:
IMPROVED PEPTIDE PHARMACEUTICALS
Timeline
Today
20.11.2013EP application
5.9.2018EP Publication
Owner
Name:
Eumederis Pharmaceuticals, Inc.Address:
12707 High Bluff Drive, Suite 200, 92130, San Diego, CA, US
Inventor
Name:
NESTOR, John, J.Address:
Encinitas, CA, US
Priority
Number:
201261728667 PDate:
20.11.2012Country:
US
Classification
Categories:
C07K 19/00, C07K 7/06, A61K 38/08, C07K 1/107, A61K 38/00, C07K 5/065, A61K 38/07, A61K 38/26, A61K 38/29, C09D 101/28